Parenteral Co-Development

Nichepharm works the way your project needs us to. Some customers arrive with a defined formulation and a process ready to transfer. Others need refinement along the way. We shape our involvement around where your product is and what it still requires.

What we bring

Our core strength is taking a parenteral product from its current state into validated commercial manufacturing. That includes full analytical method development, stability studies across the conditions your markets require, scale-up, and complete tech transfer into our own lines. Where a formulation needs reworking, we can bring in an external development partner and coordinate that work so the science and the manufacturing stay aligned.

Scope

We co-develop across general injectables and biologics, including insulin and semaglutide. Whether your product sits early in its lifecycle or is ready to move toward commercial supply, we structure the engagement to fit.

How we work

The model is yours to choose. We can run a full tech transfer of an existing process, contribute analytical and manufacturing input alongside your own team, or bring in an external development partner when the product needs reformulation work we coordinate on your behalf. Each route keeps documentation controlled and timelines protected.

From development to supply

The advantage of co-developing with Nichepharm is continuity. The team refining your process and building your methods is the same operation that will manufacture at commercial scale, so decisions made early hold up later, and the handoff most projects dread simply doesn't happen.